Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results
Document Details
Form
Filing Date
Jan 26, 2024
Document Date
Jan 24, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Dianthus Therapeutics
Issuer
DIANTHUS THERAPEUTICS, INC. /DE/
Filer
SAVITZ RYAN